Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1515-1520, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1515-1520.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mycobacterium avium Invades the
Intestinal Mucosa Primarily by Interacting with Enterocytes
Felix J.
Sangari,1,
Joseph
Goodman,2
Mary
Petrofsky,1
Peter
Kolonoski,1 and
Luiz E.
Bermudez1,*
Kuzell Institute for Arthritis and Infectious
Diseases, California Pacific Medical Center Research
Institute,1 and Pediatric Electron
Microscopy Laboratory, University of California, San
Francisco,2 San Francisco, California
Received 4 August 2000/Returned for modification 16 October
2000/Accepted 12 December 2000
 |
ABSTRACT |
Previous studies have demonstrated that Mycobacterium
avium can invade intestinal epithelial cells both in vitro and
in vivo. When given to mice orally, M. avium
preferentially interacts with the intestinal mucosa at the terminal
ileum. We evaluated the mechanism(s) of M. avium binding
and invasion of the intestinal mucosa using three different systems:
(i) electron microscopy following administration of M.
avium into an intestinal loop in mice, (ii) quantitative
comparison of the bacterial load in Peyer's patch areas of the
terminal ileum versus areas that do not contain Peyer's
patches, and (iii) investigation of the ability of M. avium to cause disseminated infection following oral
administration using B-cell-deficient mice, lacking Peyer's patches,
in comparison with C57BL/6 black mice. By all approaches, M.
avium was found to invade the intestinal mucosa by interacting
primarily with enterocytes and not with M cells.
 |
INTRODUCTION |
The advent of AIDS made it clear
that infections caused by Mycobacterium avium are acquired
primarily by the gastrointestinal route (6, 12). Although
a respiratory route of infection (by aerosol) has also been identified
(17), the fact that M. avium is an
environmental organism, adapted to live in water and soil, makes oral
ingestion the most likely manner in which the host would come into
contact with the bacterium (7, 16). In patients with AIDS
and disseminated M. avium infection, a large number of
organisms are found in the intestinal mucosa and submucosa sometime
prior to the identification of bacteremia, suggesting that intestinal
colonization precedes the onset of systemic infection (30).
Using a model of oral infection in healthy mice, we determined that
100% of the mice given M. avium orally developed
disseminated disease (2). Furthermore, M. avium, when given orally, preferentially colonizes the terminal
ileum and ascending colon among all intestinal segments
(2). Studies in vitro have shown that M. avium
can invade intestinal and respiratory epithelial cells and that the invasion is more efficient when the bacterium is incubated at 37 than
at 33°C prior to the assay (3). M. avium is
significantly more efficient in entering epithelial cells when grown to
the logarithmic phase than when grown to stationary phase
(3). In addition, M. avium, when exposed to
conditions that mimic the intestinal environment, such as low oxygen
tension and hyperosmolarity, prior to incubation with intestinal
epithelial cells, can invade intestinal epithelial cells with increased
efficiency (1).
It has been demonstrated elsewhere for a number of enteric pathogens
that M cells in the Peyer's patches are the portal of entry into
the mucosa (5, 10, 14, 18). A few organisms, however, such
as Listeria monocytogenes, preferentially use enterocytes to
enter the intestinal mucosa (28). Work with two
mycobacterial species, Mycobacterium bovis BCG and
Mycobacterium paratuberculosis, has shown that both bacteria
cross the intestinal mucosa primarily by invading M cells (9,
24).
Little is known about the manner in which M. avium interacts
with the intestinal mucosa in the host and specifically whether M cells
are the mucosal target for bacterial entry. Therefore, we sought to
examine if M cells play any role in the uptake of M. avium,
by using three approaches, i.e., the intestinal loop model, oral
infection in immunocompetent mice, and oral infection of
B-cell-deficient mice that lack Peyer's patches and M cells (11).
 |
MATERIALS AND METHODS |
Bacteria.
M. avium strain 101 (serovar 1) and
strain 104 (serovar 1) were isolated from the blood of patients with
AIDS. Bacteria were cultured in Middlebrook agar 7H10 medium (Difco
Laboratories, Detroit, Mich.), supplemented with oleic acid, albumin,
dextrose, and catalase (OADC; Difco), for 10 days at 37°C.
Morphologically similar transparent colonies
(107) of M. avium were transferred to
7H9 broth and cultured for 5 days as previously described
(logarithmic-phase growth). The culture was shaken twice daily in order
to obtain a homogeneous population of bacteria. Before infection of
animals, the bacterial suspension was harvested and vortex agitated for
2 min to disperse possible clumps. The top half of the suspension was
removed and stained with Ziehl-Neelsen stain to determine the degree of
dispersion of bacteria. Bacteria were plated onto 7H10 agar plates
before each experiment to determine the number of CFU in the inoculum.
Mice.
Pathogen-free C57BL/6J black mice used in these
experiments (female, 8 to 10 weeks old, weighing an average of 25 g) were obtained from the Jackson Laboratory (Bar Harbor, Maine) and
used after 1 to 2 weeks of quarantine. C57BL/6J B-cell-deficient mice (immunoglobulin H6 negative, 8 to 10 weeks old, and 25 g) were purchased from the Jackson Laboratory and used after 1 week of quarantine. These animals have been shown previously to lack Peyer's patches and M cells (11). For the experiments in which it
was necessary to identify intestinal segments with Peyer's patches, 10- and 12-week-old mice were used. All experiments were performed according to the guidelines of the Institute's Animal Care Use Committee.
Invasion assay in vivo.
To determine M. avium
binding to the intestinal mucosa in vivo, we adapted a loop model based
on a model originally described for Giardia muris
(26). C57BL/6 black mice were anesthetized using
intraperitoneal administration of phenobarbital and ether in
aerosol. Mice were maintained under profound anesthesia during the
whole procedure. Following anesthesia, the abdominal cavity was
carefully opened, and an approximately 3-cm-long segment of the small
intestine, above the ileocecal area, was identified. A suture line was
tied at both segment ends of the intestine, enough to close the
intestinal lumen but not to interfere with blood flow. A suspension
containing approximately 107 bacteria in Hanks'
buffered salt solution (HBSS) was injected into the proximal portion of
the isolated intestinal segment. Animals were maintained alive for 1, 2, and 3 h depending on the experiment, after which the intestinal
segment was removed, opened longitudinally, and rinsed extensively in
HBSS to remove unbound and weakly bound bacteria. Formed feces were
never observed in the terminal ileum segment of the intestines. The
removed intestine was placed in 5 ml of 7H9 broth with 20% glycerol
and homogenized using a sterile glass homogenizer. The suspension was
then serially diluted in 7H9 broth before being plated onto 7H11 agar
containing antibiotics (polymyxin B, 5 µg/ml; amphotericin B, 4.5 µg/ml; carbenicillin, 22 µg/ml; and trimethoprim, 2.0 µg/ml) to
inhibit intestinal biota, for quantitation of viable organisms
associated with intestinal mucosa-submucosa. Plates were
cultured for 20 days at 37°C in humid air. The CFU per gram of tissue
was calculated as follows: CFU per gram of tissue = (average CFU
per plate × dilution factor × 5 ml)/intestinal segment weight.
Peyer's patch areas versus non-Peyer's patch areas.
To
examine if M. avium enters the intestinal mucosa
preferentially at the Peyer's patches or by invading enterocytes in a region without Peyer's patches (or both), we used two approaches. In
the first approach, C57BL/6 mice were given M. avium
(108 bacteria) orally, and 1, 4, 24, and 48 h later, the mice (eight mice per experimental group and time point)
were sacrificed; the abdomen was opened; and four segments each of 1 cm
in length comprising a region with Peyer's patches and four segments
of intestine comprising a region without Peyer's patches were
obtained, opened longitudinally, washed, homogenized, and plated onto
7H10 agar plates to determine the number of bacteria in the mucosa. In
the second approach, we used C57BL/6J wild-type (WT) and C57BL/6J
B-cell-deficient mice (Jackson Laboratory). These mice have recently
been shown to lack Peyer's patches in the terminal ileum of intestine,
and therefore they do not possess M cells. Mice were infected with 104 bacteria orally, and at 2 days, 1 week, and 3 weeks, the terminal ileum and spleen were harvested and plated to
quantitate the bacterial load. As a control, we used Salmonella
enterica serovar Typhimurium (known to invade the intestinal
mucosa through Peyer's patches; 104 bacteria)
and harvested the mice at 4 and 24 h after oral infection. Salmonella was plated on Luria-Bertani agar.
Electron microscopy.
M. avium (strain 101) was
inoculated into the intestinal loop as described above, and at several
time points an intestinal segment was obtained, cut longitudinally, and
extensively washed in HBSS. Control mice had the intestinal loop
injected with HBSS, but not with bacteria. The intestinal segment was
cut into small pieces and fixed in ice-cold 1% glutaraldehyde in
phosphate buffer for 1 h. The small segments were immersed in 1%
OsO4 for 1 h at room temperature, dehydrated
through 50 and 80% ethyl alcohol at room temperature, embedded in L.R.
White resin, and polymerized at 52°C. Thin sections were cut and
stained with uranyl acetate and lead citrate. Electron micrographs were
made with a transmission electron microscope. Sections from intestines
of approximately 25 mice were examined.
Statistical analysis.
The comparison among the experimental
groups was evaluated for statistical significance by using Student's
t test.
 |
RESULTS |
Intestinal loop model.
To determine whether M. avium would enter the intestinal mucosa by invading M cells in the
terminal ileum, we used the intestinal loop technique and injected
M. avium into the loop. At 1, 2, and 3 h, the
intestinal segment was removed and the number of bacteria associated
with it was determined. M. avium strains 101 and 104 became
associated with the intestine in a time-related manner. While at 1 h approximately 7% of the inoculum invaded the mucosa, at 3 h the
number of bacteria associated with the intestinal mucosa increased to
approximately 45% of the inoculum (Table
1).
Electron microscopic analysis indicated that M. avium
interacts with enterocytes, and only rarely was M. avium
observed invading M cells (Fig. 1A). It
was also observed that, in the great majority of the enterocytes
(>80%), M. avium binding was associated with effacement of the intestinal mucosa (Fig. 1B and C). Once within the intestinal mucosal cells, M. avium was always observed
to reside within intracytoplasmic vacuoles (Fig. 1D). Figure 1E shows that M. avium can also invade the intestinal mucosa in the
crypts (and not only the villi), and in this case, the bacteria are
encountered intracellularly within vacuoles (Fig. 1E).


View larger version (227K):
[in this window]
[in a new window]
|
FIG. 1.
Binding and invasion of the mouse intestinal mucosa by
M. avium. (A) Interaction with an enterocyte 1 h
after administration (arrowhead); (B and C) effacement of the mucosa
(arrowhead) and alteration of actin-based microvilli (C); (D) M.
avium seen inside vacuoles (arrowhead) once within the cell
2 h following administration; (E) M. avium entering
the mucosa in an intestinal crypt. Bacteria were observed
intracellularly 2 h after administration (arrowheads).
|
|
Preferential site of invasion.
Previous work demonstrated
that, following ingestion, M. avium organisms preferentially
invaded the intestinal mucosa of the terminal ileum (2).
To evaluate the accuracy of the observation obtained by electron
microscopy suggesting that M. avium enters the intestinal
mucosa by interacting primarily with enterocytes, C57BL/6J black mice
were given 108 bacteria orally (M. avium strain 104) and the terminal ileum was harvested after 1, 4, 24, and 48 h. The intestinal segment was then cut into regions
with Peyer's patches and regions without Peyer's patches.
Quantitation of the bacteria in the intestinal segments showed that at
all time points the number of bacteria in non-Peyer's patch regions
was approximately 100-fold greater than that in Peyer's patch
segments. Also, the CFU data for Peyer's patch regions infected with
M. avium are represented by only one or two mice out of
eight per group. No mycobacteria were detected in the other M. avium-infected mice. Of note was the observation that, after an
initial peak in the number of bacteria associated with the intestinal
tract at 1 h postingestion, the number of organisms remained
constant up to 48 h (Table 2).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Interaction between M. avium and the
intestinal mucosa in the terminal ileum: Peyer's patch regions
versus non-Peyer's patch regions
|
|
Infection of B-cell-deficient mice.
Recent work has indicated
that B-cell-deficient mice do not contain Peyer's patches
(11). To examine whether the absence of Peyer's patches
and M cells would influence the uptake of M. avium by the
intestinal mucosa and consequently the number of organisms in the
spleen, C57BL/6J WT and C57BL/6J B-cell-deficient mice were infected
orally, and at different time points the bacteria in the terminal ileum
and spleen were quantified. Infection with S. enterica
serovar Typhimurium was used as the control for invasion by M cells.
The results showed that the numbers of M. avium organisms per gram of tissue were approximately the same in both C57BL/6J WT and
B-cell-deficient mice, indicating that the absence of M cells has no
impact on the ability of the bacterium to translocate (Table
3). In contrast, when S. enterica serovar Typhimurium was used, the absence of Peyer's
patches resulted in a significant decrease in the number of bacteria
invading the intestinal mucosa (Table 4).
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Numbers of Salmonella bacteria in the spleen
and terminal ileum of C57BL/6J WT and B-cell-deficient mice
|
|
Figure 2 shows a transmission electron
micrograph of the intestine of a C57BL/6J B-cell-deficient mouse with
M. avium at the host cell surface causing effacement.

View larger version (139K):
[in this window]
[in a new window]
|
FIG. 2.
Interaction between M. avium and
enterocytes in a C57BL/6 B-cell-deficient mouse. The bacterium
(arrowhead) is observed interacting with an enterocyte in the villi
2 h after administration.
|
|
 |
DISCUSSION |
We have presented evidence using three different approaches
(electron microscopy, culture of specific sites in the intestine that
do or do not contain Peyer's patches, and oral challenge of
B-cell-deficient mice) that M. avium, in contrast to
S. enterica serovar Typhimurium, invades the intestinal
mucosa by targeting enterocytes and not M cells. This
observation contrasts with data obtained with other mycobacteria. For
example, M. bovis BCG has been shown elsewhere to interact
with Peyer's patch tissue following oral infection (9).
In addition, M. paratuberculosis invasion of the intestinal
tract has been associated with M cells (24). More
recently, M. tuberculosis was shown to translocate the
bronchial mucosa by entering M cells, although this observation could
not be extrapolated in regard to possible intestinal invasion
mechanisms of M. tuberculosis (36). These
characteristics of M. bovis BCG might be associated with the
inability to cause infection through the intestinal route, since this
organism would be transported to submucosal macrophages following
M-cell translocation and very likely eliminated or suppressed. It is
certainly an important question whether virulent M. bovis
uses the same path to cross the intestinal barrier
in cattle.
Enteropathogens interact with the intestinal mucosa in many ways, but M
cells have been shown elsewhere to be the target for Yersinia
pseudotuberculosis (although it also invades enterocytes), S. enterica serovar Typhimurium, and Shigella
flexneri (8, 10, 19, 27). The fact that M. avium invades the intestinal mucosa primarily through enterocytes
may have evolutionary implications and is likely to be important for
the pathogenesis of the infection. One of the evolutionary aspects to
be considered is why M. avium, but not Mycobacterium
intracellulare, is efficient in crossing the intestinal mucosal
barrier (N. Hsu, J. R. Goodman, L. S. Young, and L. E. Bermudez, Abstr. 36th Intersci. Conf. Antimicrob. Agents Chemother.,
abstr. B25, p. 26, 1996). We are currently attempting to characterize
genomic differences between these two organisms to better understand
the difference in pathogenesis.
Another important aspect is the question of virulence. One hypothesis
is that M. avium, which appears to have less intrinsic virulence than M. tuberculosis, evolved to follow an entry
path that would delay the exposure of the bacterium to the immune
system of the host. All the evidence so far agrees with this
hypothesis. For example, a previous study by our laboratory
(20) has shown that oral-gastrointestinal infection by
M. avium in mice is not accompanied by the inflammatory
response until approximately 1 week after infection. This finding
suggests that the bacterium may initially hide from the immune system
of the host within the epithelial cell. In addition, we showed that
infection of intestinal epithelial cells in vitro with M. avium does not trigger chemokine production and that M. avium infection suppresses Salmonella-triggered interleukin-8 production by epithelial cells (33). A
similar observation was made using a central nervous system model of
M. avium infection in mice, in which invasion of the brain
parenchyma is not accompanied by an inflammatory response
(37) and the mice with M. avium infection in
the brain can live for long periods without any apparent symptoms
(37). In line with this hypothesis, after 2 to 3 days
inside intestinal epithelial cells, M. avium is capable of
expressing an invasive phenotype that enhances the ability of the
bacterium to enter macrophages and survive intracellularly (31).
M. avium entry into the intestinal mucosa was observed to be
associated with effacement. Several other organisms, such as enteropathogenic Escherichia coli (EPEC), enterohemorrhagic
E. coli, Citrobacter rodentium,
Hafnia alvei, and Helicobacter pylori, have been
shown previously to induce attachment-effacement of the epithelial cell
upon contact (4, 23, 35). EPEC does not enter the host
cell (26), and the fate of H. pylori is still arguable (13). Effacement triggered by EPEC is dependent
on the presence of EspA, EspB, and EspD, and mutation in each of those
factors prevents adhering-effacing lesion formation
(25). Whether M. avium-induced effacement is
needed to uncover the epithelial cell membrane and expose the cell
membrane receptor(s) is a possibility currently being investigated.
In the process of invasion, alteration of the actin was observed,
confirming previous in vitro data (3, 22, 29). The bacteria were always observed to be inside cytoplasmic vacuoles, supporting findings in different model systems (31, 32).
Although not much is currently known about the M. avium
adhesins, a recent study by Labo and colleagues that sequenced a large region of the M. avium genome has identified two genes
(invA and invB) with homology to the p60 invasion
protein of L. monocytogenes (21). Furthermore,
work by Hess and colleagues suggests that the p60-dependent entry of
Listeria into the mucosa occurs through the enterocyte,
which would support a role for the p60 homolog in the binding of
M. avium to the intestinal mucosa (15). Another putative adhesin, a fibronectin attaching protein, has been
characterized for M. avium and other mycobacteria
(34). This adhesin binds integrin and is expected to
connect the bacterium to the
1 integrin receptor. Because
1
integrin is present only on M cells in the intestinal tract, this
mechanism should not be involved in the invasion of enterocytes.
More recently, we have identified several genes that appear to
participate in intestinal epithelial cell invasion, though future
confirmation in an animal model is required (E. Miltner, A. Parker,
F. J. Sangari, and L. E. Bermudez, Abstr. 100th Gen. Meet.
Am. Soc. Microbiol., abstr. U-29, p. 648, 2000).
In conclusion, we have shown that M. avium invades the
intestinal mucosa in vivo by using enterocytes as target cells, a
characteristic that might be associated with the ability to cause disease.
 |
ACKNOWLEDGMENTS |
We thank Karen Allen for preparing the manuscript and Dirk Wagner
and Martin Wu for help with the art montage. We also thank Stanley
Falkow for very fruitful discussions; Robert Owen for his help with the
work with M cells; and Dirk Wagner, Jeffery McGarvey, and Lowell S. Young for critically reviewing the manuscript.
This work was supported by grant AI43199 from the National Institutes
of Health and grant R99-CHSF-091 from the U.C. Task Force on AIDS.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Kuzell
Institute, 2200 Webster St., Suite 305, San Francisco, CA 94115. Phone:
(415) 561-1734. Fax: (415) 441-8548. E-mail: luizb{at}cooper.cpmc.org.
Present address: Department of Molecular Biology, University of
Cantabria, Santander, Spain.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Bermudez, L. E.,
M. Petrofsky, and J. Goodman.
1997.
Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.
Infect. Immun.
65:3768-3773[Abstract].
|
| 2.
|
Bermudez, L. E.,
M. Petrofsky,
P. Kolonoski, and L. S. Young.
1992.
An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract.
J. Infect. Dis.
165:75-79[Medline].
|
| 3.
|
Bermudez, L. E., and L. S. Young.
1994.
Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex.
Infect. Immun.
62:2021-2026[Abstract/Free Full Text].
|
| 4.
|
Celli, J.,
W. Deng, and B. B. Finlay.
2000.
Enteropathogenic Escherichia coli (EPEC) attachment to epithelial cells: exploiting the host cell skeleton from the outside.
Cell. Microbiol.
2:1-9[CrossRef][Medline].
|
| 5.
|
Clark, A. M.,
M. A. Jepson,
N. L. Simmons, and B. H. Hirst.
1994.
Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells.
Res. Microbiol.
145:543-552[Medline].
|
| 6.
|
Damsker, B., and E. J. Bottone.
1985.
Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis.
J. Infect. Dis.
151:179-181[Medline].
|
| 7.
|
Falkinham, J. O., III.
1996.
Epidemiology of infection by nontuberculous mycobacteria.
Clin. Microbiol. Rev.
9:177-215[Medline].
|
| 8.
|
Finlay, B. B., and S. Falkow.
1997.
Common themes in microbial pathogenicity revisited.
Microbiol. Mol. Biol. Rev.
61:136-169[Abstract].
|
| 9.
|
Fujimora, Y.
1986.
Functional morphology.
Gastroenterol. Jpn.
21:325-330[Medline].
|
| 10.
|
Fujimora, Y.,
T. Kihara, and H. Mine.
1992.
Membranous cells as a portal of Yersinia pseudotuberculosis entry into rabbit ileum.
J. Clin. Electron Microsc.
25:34-45.
|
| 11.
|
Golovkina, T. V.,
M. Shlomchik,
L. Hannum, and A. Chervonsky.
1999.
Organogenic role of B lymphocytes in mucosal immunity.
Science
286:1965-1968[Abstract/Free Full Text].
|
| 12.
|
Gray, J. R., and L. Rabeneck.
1989.
Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients.
Am. J. Gastroenterol.
84:1521-1524[Medline].
|
| 13.
|
Guruge, J. L.,
P. G. Falk,
R. G. Lorenz,
M. Dans,
H. P. Wirth,
M. J. Blaser,
D. E. Berg, and J. I. Gordon.
1998.
Epithelial attachment alters the outcome of Helicobacter pylori infection.
Proc. Natl. Acad. Sci. USA
95:3925-3930[Abstract/Free Full Text].
|
| 14.
|
Hanski, C.,
U. Kutschka,
H. P. Schmoranzer,
M. Naumann,
A. Stallmach,
H. Hahn,
H. Menge, and E. O. Riecken.
1989.
Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis.
Infect. Immun.
57:673-678[Abstract/Free Full Text].
|
| 15.
|
Hess, J.,
A. Dreher,
I. Gentschev,
W. Goebel,
C. Ladel,
D. Miko, and S. H. Kaufmann.
1996.
Protein p60 participates in intestinal host invasion by Listeria monocytogenes.
Zentbl. Bakteriol.
284:263-272.
|
| 16.
|
Inderlied, C. B.,
C. A. Kemper, and L. E. Bermudez.
1993.
The Mycobacterium avium complex.
Clin. Microbiol. Rev.
6:266-310[Abstract/Free Full Text].
|
| 17.
|
Jacobson, A. M.,
P. C. Hopewell,
D. M. Yajko,
W. K. Hadley,
E. Lazarus,
P. K. Mohanty,
G. W. Modin,
D. W. Feigal,
P. S. Cusick, and M. A. Sande.
1991.
Natural history of disseminated Mycobacterium avium complex infection in AIDS.
J. Infect. Dis.
164:994-998[Medline].
|
| 18.
|
Jones, B.,
L. Pascopella, and S. Falkow.
1995.
Entry of microbes into the host: using M cells to break the mucosal barrier.
Curr. Opin. Immunol.
7:474-478[CrossRef][Medline].
|
| 19.
|
Jones, B. D.,
N. Ghori, and S. Falkow.
1994.
Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.
J. Exp. Med.
180:15-23[Abstract/Free Full Text].
|
| 20.
|
Kim, S. Y.,
J. R. Goodman,
M. Petrofsky, and L. E. Bermudez.
1998.
Mycobacterium avium infection of gut mucosa in mice associated with late inflammatory response and intestinal cell necrosis.
J. Med. Microbiol.
47:725-731[Abstract].
|
| 21.
|
Labo, M.,
L. Gusberti,
E. D. Rossi,
P. Speziale, and G. Riccardi.
1998.
Determination of a 15437 bp nucleotide sequence around the inhA gene of Mycobacterium avium and similarity analysis of the products of putative ORFs.
Microbiology
144:807-814[Abstract].
|
| 22.
|
Mapother, M. E., and J. G. Songer.
1984.
In vitro interaction of Mycobacterium avium with intestinal epithelial cells.
Infect. Immun.
45:67-73[Abstract/Free Full Text].
|
| 23.
|
McDaniel, T. K., and J. B. Kaper.
1997.
A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12.
Mol. Microbiol.
23:399-407[CrossRef][Medline].
|
| 24.
|
Momotani, E.,
D. L. Whipple,
A. B. Thiermann, and N. F. Cheville.
1988.
Role of M cells and macrophages in the entrance of Mycobacterium paratuberculosis into domes of ileal Peyer's patches in calves.
Vet. Pathol.
25:131-137[Abstract].
|
| 25.
|
Nataro, J. P., and J. B. Kaper.
1998.
Diarrheagenic Escherichia.
Clin. Microbiol. Rev.
11:142-201[Abstract/Free Full Text].
|
| 26.
|
Owen, R. L.,
P. C. Nemanic, and D. P. Stevens.
1979.
Ultrastructural observations on giardiasis in a murine model. I. Intestinal distribution, attachment, and relationship to the immune system of Giardia muris.
Gastroenterology
76:757-769[Medline].
|
| 27.
|
Perdomo, O. J.,
J. M. Cavaillon,
M. Huerre,
H. Ohayon,
P. Gounon, and P. J. Sansonetti.
1994.
Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis.
J. Exp. Med.
180:1307-1319[Abstract/Free Full Text].
|
| 28.
|
Racz, P.,
K. Tenner, and E. Mero.
1972.
Experimental Listeria enteritis. I. An electron microscopic study of the epithelial phase in experimental listeria infection.
Lab. Investig.
26:694-700[Medline].
|
| 29.
|
Reddy, V. M., and B. Kumar.
2000.
Interaction of Mycobacterium avium complex with human respiratory epithelial cells.
J. Infect. Dis.
181:1189-1193[CrossRef][Medline].
|
| 30.
|
Roth, R. I.,
R. L. Owen,
D. F. Keren, and P. A. Volberding.
1985.
Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS). Histological and clinical comparison with Whipple's disease.
Dig. Dis. Sci.
30:497-504[CrossRef][Medline].
|
| 31.
|
Sangari, F.,
J. Goodman, and L. E. Bermudez.
2000.
Mycobacterium avium enters intestinal epithelial cells through the apical membrane but not by the basolateral surface, activates small GTPase Rho and once within the epithelial cells expresses an invasive phenotype.
Cell. Microbiol.
2:561-568[CrossRef][Medline].
|
| 32.
|
Sangari, F. J.,
J. R. Goodman, and L. E. Bermudez.
2000.
Ultrastructural study of Mycobacterium avium infection of HT-29 human intestinal epithelial cells.
J. Med. Microbiol.
49:139-147[Abstract/Free Full Text].
|
| 33.
|
Sangari, F. J.,
M. Petrofsky, and L. E. Bermudez.
1999.
Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES.
Infect. Immun.
67:5069-5075[Abstract/Free Full Text].
|
| 34.
|
Schorey, J. S.,
M. A. Holsti,
T. L. Ratliff,
P. M. Allen, and E. J. Brown.
1996.
Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria.
Mol. Microbiol.
21:321-329[CrossRef][Medline].
|
| 35.
|
Segal, E. D.,
S. Falkow, and L. S. Tompkins.
1996.
Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins.
Proc. Natl. Acad. Sci. USA
93:1259-1264[Abstract/Free Full Text].
|
| 36.
|
Teitelbaum, R.,
W. Schubert,
L. Gunther,
Y. Kress,
F. Macaluso,
J. W. Pollard,
D. N. McMurray, and B. R. Bloom.
1999.
The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis.
Immunity
10:641-650[CrossRef][Medline].
|
| 37.
|
Wu, H. S.,
P. Kolonoski,
Y. Y. Chang, and L. E. Bermudez.
2000.
Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice.
Infect. Immun.
68:2979-2984[Abstract/Free Full Text].
|
Infection and Immunity, March 2001, p. 1515-1520, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1515-1520.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wu, C.-w., Livesey, M., Schmoller, S. K., Manning, E. J. B., Steinberg, H., Davis, W. C., Hamilton, M. J., Talaat, A. M.
(2007). Invasion and Persistence of Mycobacterium avium subsp. paratuberculosis during Early Stages of Johne's Disease in Calves. Infect. Immun.
75: 2110-2119
[Abstract]
[Full Text]
-
Flaherty, D. K., Vesosky, B., Beamer, G. L., Stromberg, P., Turner, J.
(2006). Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. J. Leukoc. Biol.
80: 1262-1271
[Abstract]
[Full Text]
-
Miltner, E., Daroogheh, K., Mehta, P. K., Cirillo, S. L. G., Cirillo, J. D., Bermudez, L. E.
(2005). Identification of Mycobacterium avium Genes That Affect Invasion of the Intestinal Epithelium. Infect. Immun.
73: 4214-4221
[Abstract]
[Full Text]
-
Petrofsky, M., Bermudez, L. E.
(2005). CD4+ T Cells but Not CD8+ or {gamma}{delta}+ Lymphocytes Are Required for Host Protection against Mycobacterium avium Infection and Dissemination through the Intestinal Route. Infect. Immun.
73: 2621-2627
[Abstract]
[Full Text]
-
Secott, T. E., Lin, T. L., Wu, C. C.
(2004). Mycobacterium avium subsp. paratuberculosis Fibronectin Attachment Protein Facilitates M-Cell Targeting and Invasion through a Fibronectin Bridge with Host Integrins. Infect. Immun.
72: 3724-3732
[Abstract]
[Full Text]
-
Kurade, N. P., Tripathi, B. N., Rajukumar, K., Parihar, N. S.
(2004). Sequential Development of Histologic Lesions and Their Relationship with Bacterial Isolation, Fecal Shedding, and Immune Responses during Progressive Stages of Experimental Infection of Lambs with Mycobacterium avium subsp. paratuberculosis. Vet Pathol
41: 378-387
[Abstract]
[Full Text]
-
Primm, T. P., Lucero, C. A., Falkinham, J. O. III
(2004). Health Impacts of Environmental Mycobacteria. Clin. Microbiol. Rev.
17: 98-106
[Abstract]
[Full Text]
-
Bannantine, J. P., Huntley, J. F. J., Miltner, E., Stabel, J. R., Bermudez, L. E.
(2003). The Mycobacterium avium subsp. paratuberculosis 35 kDa protein plays a role in invasion of bovine epithelial cells. Microbiology
149: 2061-2069
[Abstract]
[Full Text]